News | Biotome

top of page

Search

Biotome’s peptide augmentation technology ensures structured orientation and enhanced antibody accessibility.

Biotome’s peptide augmentation technology ensures structured orientation and enhanced antibody accessibility.

Patent Filed: Peptide Augmentation Technology

Jun 16

Biotome Heads to Boston: Meet Us at BIO 2025

Biotome Heads to Boston: Meet Us at BIO 2025

Biotome Heads to Boston: Meet Us at BIO 2025

Jun 14

Our first manufactured 96-well ELISA microplate.

Our first manufactured 96-well ELISA microplate.

Biotome Achieves Manufacturing Milestone in Gastric Cancer Prevention

May 30

bottom of page